title: Development of aberrant crypt foci in the colons of ob/ob and db/db mice: evidence that leptin is not a promoter.
abstract: Leptin is elevated in obesity and has been suggested to increase the risk of colorectal cancer (CRC), although the evidence is conflicting. The objective of this study was to compare the susceptibility to colon carcinogenesis of db/db mice that have highly elevated circulating leptin and leptin-deficient ob/ob mice, both of which are obese. Seven-week-old male ob/ob, db/db, and WT mice received 4 weekly i.p. injections of 5 mg/kg azoxymethane (AOM) and were killed 14 wk later for the analysis of putative preneoplastic aberrant crypt foci (ACF). There were no differences in ACF number or multiplicity between ob/ob and db/db mice. Leptin has been shown to induce CYP2E1, the main enzyme that activates AOM, but we observed no differences in hepatic CYP2E1 activity or colonic CYP2E1 protein levels between ob/ob and db/db mice. We also induced ACF with 2 oral doses 3 d apart of 30 mg/kg methylnitrosourea (MNU), a direct-acting carcinogen. There were no differences in ACF number or multiplicity between the two groups of obese animals 5 wk following the last dose of MNU. The colonic mucosa of db/db mice expressed significantly lower mRNA levels of ObRa, the predominant short form of the leptin receptor, compared to ob/ob mice, and following i.p. injection with 1 mg/kg recombinant mouse leptin, exhibited significantly reduced p44/42 pMAPK compared to saline-treated controls. These results show that ObRa is functionally active in the colons of db/db mice. We conclude that leptin does not play a significant role in ACF development.
authors.affiliation: Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Canada.
authors.forename: Kafi N
authors.initials: KN
authors.lastname: Ealey
authors.forename: Suying
authors.initials: S
authors.lastname: Lu
authors.forename: Michael C
authors.initials: MC
authors.lastname: Archer
mesh_terms: D000818:Animals; D002273:Carcinogens / Q000633:toxicity; D015179:Colorectal Neoplasms / Q000235:genetics*; D019392:Cytochrome P-450 CYP2E1 / Q000235:genetics; D020022:Genetic Predisposition to Disease; D020738:Leptin / Q000235:genetics*; D008770:Methylnitrosourea / Q000633:toxicity; D051379:Mice; D008810:Mice, Inbred C57BL; D008820:Mice, Obese / Q000235:genetics; D008861:Microsomes / Q000473:pathology; D011401:Promoter Regions, Genetic; D054411:Receptors, Leptin / Q000235:genetics
chemical_list: D002273:Carcinogens; D020738:Leptin; D054411:Receptors, Leptin; D008770:Methylnitrosourea; D019392:Cytochrome P-450 CYP2E1